Introduction
The elderly are generally considered to be differ ent from young people in terms of drug response. It is reported that the frequency of intoxication caused by drugs is higher in the elderly than the young.1) While altered drug handling is a major potential source of difference in responsiveness to drugs, the relative contribution of pharmacokinetics and pharmacodynamics to this difference is not clear.
Recently benzodiazepines have been used not only as a sedative but also as a premedicant drug. 2) In the present study two benzodiazepines (BDP), diazepam (DZP) and lorazepam (LZP), were studied to elucidate age differences in the kinetics of these drugs.
Volunteers and Methods
Seven young Japanese men (Y: 22-25 yr) and 10 aged Japanese men and women (A: 67-90 yr) took (47-68 kg) in the elderly. All subjects submitted informed written consent before participating in the study. Subjects were free of identifiable med ical or psychiatric disease and none had a history of regular drug use.
The schedule of drug administration in subjects was randomized according to a Latin square design and at least 2 wk elapsed between trials. Each subject took diazepam (one 5-mg tablet) or loraze pam (one or two 1-mg tablets) between 08 : 15 and 08 : 30 am, with 180 ml of water after fasting overnight.
Subjects remained fasting for 4 hr after each benzodiazepine dose after which time they resumed their normal diet. Blood samples (5 ml) were drawn from the ante-cubital vein prior to the dose and at 0. may support the assumption of F=1 in our calcula tion.6) Statistical analysis The mean and standard deviation of each pa rameter were calculated for each group. The vari ances of means were tested for homoscedasticity and when variances were found to be homoge neously distributed values were compared by Student's t-test, Wilcoxon two sample test.
Results
There was considerable inter-individual variation in plasma concentrations of both benzodiazepines. Mean plasma lorazepam and diazepam concentra tions are given in Figs. 1 and 2 and concentrations of one of the metabolites, N-desmethyldiazepam, are shown in Fig. 3 . Table 1 shows the individual details of the young and elderly volunteers. Table  2 shows the pharmacokinetic parameters of the two benzodiazepines in the young and elderly.
Diazepam
The elimination half-life was prolonged in the elderly compared with the young (P<0.05) and the volume of distribution was increased in the elderly (P<0.05).
However there were no signifi cant differences between the two groups in the was not significant between the two groups at the 5% significance level.
Discussion
The effects of age on the pharmacokinetics of benzodiazepines have already been studied in Western people, but there has not as yet been a systematic study carried out in Japanese people. In the present study, the pharmacokinetics of diazepam and lorazepam in Japanese young and elderly people were studied and compared.
Lorazepam
The study of lorazepam pharmacokinetics in Western elderly subjects, 60 to 84 yr of age, gave a value for the elimination half-life of 15.9hr, and in the young volunteers from (19 to 38yr), the half-life was 14.1hr and 14.3hr.6) In this report there were no significant differences between the young and the elderly. It was also shown that the half-life of lorazepam was independent of dose and A large proportion (approximately 75% of administered dose) of lorazepam is conjugated with glucuronic acid and the glucuronide conjugate is rapidly excreted into urine. However, a small proportion of lorazepam is metabolized by hepatic oxidation processes and some derivatives, such as quinazoline derivatives, hydroxylorazepam and un In this study it was shown that apparent vol umes of distribution were not different, and total clearance in the elderly was reduced. Kraus and co-workers observed a weak negative correlation of lorazepam clearance with age among 11 subjects, 15 to 75 yr of age.10) In Japanese people, however, there have been no studies undertaken to investigate age-related differ ences in pharmacokinetics for diazepam. In our study the elimination half-life in the young was 65.4hr.
This shows that the elimination half-life of diazepam in Japanese young people is relatively long compared with that of Western young people. However, in the elderly group the half-lives were shown to be consistent with those of Western elderly people.
The volumes of distribution were larger in elderly people (5% significance level) whereas clearance was almost identical. Thus it appears that the prolongation of elimination half-life of diazepam in the elderly is primarily dependent on an increase in the volume of distribution of the drug. Diazepam is primarily metabolized by the microsomal mixed function oxidases in the liver. In humans, the main pathway of diazepam biotransformation is N-demethylation, yielding N desmethyldiazepam. N-Desmethyldiazepam is then oxidized at the 3-position to convert it to oxazepam, which is eliminated almost entirely as glucuronide conjugates. 14, 15) The effect of age on glucuronide conjugation of foreign chemicals by man is not well understood. Studies with acetaminophen, another drug metabolized principally by glucuronide conjugation, were suggestive of prolonged t1/2 and reduced clearance in the elderly. 16, 17) Although in our study the half lives of lorazepam were not statistically different in the 2 groups, in the case of over 85 yr, t1/2 tended to be prolonged and clearance was reduced. Even with lorazepam the capacity of glucuronidation appears to be limited in ex tremely elderly people. These results indicate that age has probably dif ferent influences on the kinetics of diazepam and lorazepam due to the different metabolic character istics of the two drugs, since lorazepam is directly metabolized to glucuronide conjugates whereas diaz epam is metabolized oxidation prior to glucuronide conjugation.
